UK-BASED SUPPLIER · ESTABLISHED 2023
Research-grade peptides, verified by third-party analysis.
Supplied to independent researchers, academic laboratories, and accredited institutions. Purity verified by HPLC and mass spectrometry on every batch.
≥98%
HPLC PURITY
3pm
DISPATCH CUT-OFF
-20°C
COLD CHAIN
COA
PER BATCH
Most studied compounds
Latest from the peptide industry
Pharma & GLP-1
EMA's CHMP Backs Orforglipron for the EU: What the Non-Peptide GLP-1 Opinion Means for the Research Landscape
The EMA's Committee for Medicinal Products for Human Use issued a positive opinion on 15 October 2026 recommending EU marketing authorisation for Eli Lilly's orforglipron (Foundayo) — a non-peptide, small-molecule GLP-1 receptor agonist. The decision, pending a European Commission rubber-stamp expected within weeks, adds regulatory momentum to a drug that differs structurally from every peptide GLP-1 approved to date, with consequences for manufacturing, compounding policy, and research-supply…
17 Oct 2026
Reputational Risks
Black Mould, Falsified Records, and Import Alert 66-40: What FDA Inspection Reports Reveal About Chinese GLP-1 API Suppliers
FDA inspection reports obtained under FOIA reveal black mould on equipment, insect contamination, destruction of samples during inspection, and falsified documentation at two Chinese manufacturers of semaglutide and tirzepatide active pharmaceutical ingredients. Both firms — Chengdu Shengnuo Biopharm and Nanjing Chengong Pharmaceutical — have been placed on Import Alert 66-40, with direct implications for compounding pharmacy supply chains and research-procurement quality assurance.
16 Oct 2026
Reputational Risks
Supplement-Grade API in Injectable Vials: The Glutathione Contamination Cluster That Illuminates a Systemic Compounding Risk
At least four US compounding pharmacies have recalled injectable glutathione products since August 2026 after elevated endotoxin levels were traced to a supplement-grade active pharmaceutical ingredient. Dozens of people have been sickened across multiple states. For research-procurement professionals, the cluster illustrates the specific hazard of API provenance gaps that can affect any compounded peptide injectable — not only the compounds currently under regulatory scrutiny.
15 Oct 2026
Every batch, documented.
HPLC purity analysis, mass spectrometry confirmation, and batch traceability — downloadable per product, matched to the batch code on your vial.
View our methodology →
Cold chain maintained.
Lyophilised product held at -20°C in temperature-controlled storage from receipt to dispatch. Stability guaranteed under documented conditions.
Storage protocols →
Same-day, plain packaging.
Orders placed before 3pm, Monday to Friday, dispatched the same working day. Tracked UK delivery, discreet unbranded packaging as standard.
Shipping & returns →